Basel, Switzerland- and Boston, MA-based biotechnology company developing a novel approach to cell therapies
Cimeio Therapeutics has raised €328M across 2 funding rounds from 2 investors, most recently a round in Dec 2024. Based in Basel, Switzerland; active in Healthtech. Data as of 7 Aug 2026.
Timing: in window vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2024-12-12 | Other | €282M | Kyowa Kirin | View deal → |
| 2022-04-18 | Series A | €46M | Versant Ventures | View deal → |
